Update: TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance
(Updates with the latest stock move in the headline and the first paragraph.)TriSalus Life Sciences (TLSI) shares were up 5.9% in Wednesday trading after the company said late Tuesday it received US Food and Drug Administration clearance for TriNav Advance, the newest addition to its Pressure-Enabled Drug Delivery portfolio.TriNav Advance provides access to small, distal vessels via a compatible delivery microcatheter, the company said.The company said it plans to initiate a limited market release of the TriNav Advance device over the coming weeks.Price: $5.22, Change: $+0.29, Percent Change: +5.88%